Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 35.85% | -16.01% | -8.61% | 15.49% | 32.70% |
| Total Depreciation and Amortization | -56.32% | -60.22% | -67.30% | -52.68% | 0.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -- | -- | -- | 1,374.23% |
| Change in Net Operating Assets | 76.24% | -2,563.01% | -1,762.84% | -2,063.96% | -344.64% |
| Cash from Operations | 49.67% | -130.58% | -316.79% | -173.95% | -222.20% |
| Capital Expenditure | 69.27% | 48.28% | 74.42% | 42.99% | 67.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 64.20% | 32.87% | 85.77% | 57.41% | 70.74% |
| Total Debt Issued | -40.33% | -33.43% | -56.23% | -56.60% | -30.32% |
| Total Debt Repaid | -75,636.36% | -- | -- | -- | -- |
| Issuance of Common Stock | 2.49% | -- | -- | -- | 48,196.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8,667.45% | -8,010.93% | -5,344.32% | -6,435.01% | 88.46% |
| Cash from Financing | -100.71% | 230.92% | 207.76% | 217.89% | 601.35% |
| Foreign Exchange rate Adjustments | 45.32% | -96.95% | 102.51% | -167.24% | -113.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.37% | 99.41% | -84.11% | 2,169.23% | 1,778.09% |